Yeah,I too was disappointed with the small cohort, but I can understand the complexities of recruiting suitable candidates for trialing a novel drug. The main thing is that they were able to extract meaningful data and demonstrate a mechanism of action.
I think recruiting issues have been addressed for Phase 2b. The 8 - 10 dogs should come through much quicker than before. With the refined dosage regime I would expect 100% progression free survival and perhaps even notable reductions in tumor burdens.
If we attain these sort of results, it will be enough evidence to advance to a large scale Phase 3 with perhaps hundreds of dogs. But we won't have to do it on our own. I reckon the current trial will be closely monitored by a number of interested parties that may or may not include "Vet Major".
Cheers, Thrifty
- Forums
- ASX - By Stock
- Ann: Appendix 4C and Quarterly Update
Yeah,I too was disappointed with the small cohort, but I can...
-
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $97.22M |
Open | High | Low | Value | Volume |
20.0¢ | 20.0¢ | 19.5¢ | $244.3K | 1.244M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 257206 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.195 |
15 | 925498 | 0.190 |
11 | 271447 | 0.185 |
17 | 418587 | 0.180 |
3 | 259030 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 257206 | 7 |
0.205 | 247264 | 3 |
0.210 | 193616 | 5 |
0.215 | 353018 | 4 |
0.220 | 479713 | 7 |
Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online